Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

A central Ohio biotechnology company that operated facilities in West Jefferson and New Albany has shut down, resulting in ...

GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore's premier biotech ...

The biotech mergers and acquisitions market faces significant headwinds in the first half of 2025. These challenges include frozen capital ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Switzerland's Xlife Sciences AG said on Wednesday its portfolio company, VERAXA Biotech AG, will merge with Voyager Acquisition in a deal that will value the combined company at $1.64 billion. The ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...